The Pfizer and AstraZeneca COVID-19 shots will be combined in a 'mix and match' trial to see if the 2 vaccines together produce a stronger immune response
- The head of the
UK's vaccinetaskforce said Tuesday that a "mix and match" trial will combine both Pfizerand AstraZeneca's COVID-19vaccines.
- The trial will test whether combining the two shots works better than administering them individually.
- AstraZeneca and Oxford's vaccine has not yet been approved by UK regulators, but once it is, the trials will kick off.
- Pfizer's COVID-19 vaccine has been approved in the UK, and the first shots were given out Tuesday.
- During the trials, patients will receive one dose of the Pfizer shot and another of the vaccine made by AstraZeneca and Oxford University. The two shots trigger different immune responses.
The UK is planning to combine the Pfizer and AstraZeneca vaccines in trials next year to see if both shots together produce a stronger immune response than giving them individually.Patients who participate in January's "mix and match" trial - which will begin when AstraZeneca and Oxford's vaccine is approved, will receive one dose of the Pfizer shot and another of the Oxford shot.
"It means mix and matching vaccines," she said at the launch of a report on the group's progress."So you do a prime with one vaccine and then the second - whether it's 28 days or two months or whatever the agreed periods would be - would be with a different vaccine." Both vaccines work in different ways. Typically, mRNA vaccines, such as Pfizer's, produce a greater antibody response, whereas viral-based vaccines such as AstraZeneca's give a bigger cellular response.
"Antibodies block the uptake of viruses into cells and the cellular T-cells identify those cells that have been infected and take them out. You ideally want to have both," Bingham said.
Clive Dix, deputy chair of the taskforce, said at the event: "No one's ever done it live and since we'll have safe vaccines available we should do that study, because then we have the ability to actually produce better immune responses."
- Cannes Lions 2021: On Day 3, Dentsu Webchutney brings home 2 Silver Lions
- Best laptop for students in India in 2021
- Twitter rolls out new update for iOS allowing users to share tweets to Instagram stories
- If you are vaccinated, IndiGo Airlines is giving discounts on airfares
- Microsoft joins Apple in $2 Trillion Club